ATH Price sensitive 28 Jul 2025, 9:59 AM

Positive ATH434 Results from Open-Label Phase 2 Trial in MSA

Alterity Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in